NCT01696136已完成不适用
Multi-electrode PulmonarY Vein Isolation Versus Single Tip Wide Area Catheter Ablation for PAF a Randomized Multinational Multicenter Trial
L.V.A. Boersma2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2011年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
- 试验地点
- 2
- 主要终点
- Freedom of AF
研究概览
简要总结
The MYSTIC_PAF trial investigates the differences between treatment with a single-tip catheter against a multielectrode catheter in cardiac ablation procedures in patients with paroxysmal atrial fibrillation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •History of symptomatic paroxysmal atrial fibrillation defined as:
- •Self-terminating AF with episodes lasting no more than seven consecutive days before spontaneous conversion back to sinus rhythm
- •Documentation of one or more events with PAF tracings by ECG, event recordings, pacemaker strips or monitor rhythm strips within the past year
- •AF symptoms defined as the manifestation of any of the following:
- •Palpitations
- •Exertional dyspnea
- •Effort intolerance
- •Age between 18 and 70
- •Willingness, ability and commitment to participate in baseline and follow-up evaluations for the full length of the study
排除标准
- •Structural heart disease of clinical significance including:
- •Previous cardiac surgery (excluding CABG)
- •Symptoms of congestive heart failure including, but not limited to, NYHA Class III or IV CHF and/or documented ejection fraction < 40% measured by acceptable cardiac testing
- •Left atrial diameter of > 50mm as measured in the parasternal long axis on transthoracic echocardiogram
- •Stable/unstable angina or ongoing myocardial ischemia
- •Myocardial infarction (MI) within three months of enrollment
- •Aortic or mitral valve disease > Grade II
- •Congenital heart disease (not including ASD or PFO without a right to left shunt) where the underlying abnormality increases the risk of an ablative procedure
- •Prior ASD or PFO closure with a device using a percutaneous approach
- •Hypertrophic cardiomyopathy (LV wall thickness > 1.5 cm)
- •Pulmonary hypertension (mean or systolic PA pressure >50mm Hg on Doppler echo
- •Prior ablation for arrhythmias other than AF within the past three months
- •Prior left sided AF ablation
- •Enrollment in any other ongoing arrhythmia study protocol Any ventricular tachyarrhythmias currently being treated where the arrhythmia or the management may interfere with this study
结局指标
主要结局
Freedom of AF
时间窗: Month 3 after intervention
Is the patient free of Atrial Fibrillation, at month 3 after the ablation intervention, and not taking anti-arrhythmic drugs
次要结局
未报告次要终点
研究者
L.V.A. Boersma
Cardiologist
R&D Cardiologie
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Multi-electrode PulmonarY Vein isolation vs Single Tip wide area Catheter ablation for Paroxysmal Atrial Fibrillatioatrial fibrillationheartrhythm disorder10007521NL-OMON36751R&D Cardiologie80
已完成
4 期
Trigger- vs. Substrate-Ablation for Paroxysmal Atrial FibrillationAtrial FibrillationNCT00196183Deutsches Herzzentrum Muenchen98
进行中（未招募）
4 期
SINGLE SHOT CHAMPIONParoxysmal Atrial FibrillationNCT05534581Insel Gruppe AG, University Hospital Bern210
终止
不适用
Comparison of PVI Plus Catheter Ablation or PVI Alone for the Treatment of AFib for Patients With Paroxysmal Atrial FibrillationAtrial FibrillationNCT03115554Wake Forest University Health Sciences2
尚未招募
不适用
CPVI Alone Versus CPVI Plus Low-Voltage Areas Ablation During SR Versus CPVI Plus Low-Voltage Areas Ablation During AF for the Treatment of CAFAtrial FibrillationNCT06499818Yantai Yuhuangding Hospital150